Ignite Creation Date:
2024-05-06 @ 1:53 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04152499
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2019-10-29
Brief Title:
Phase I-II FIH TROP2 ADC Advanced UnresectableMetastatic Solid Tumors Refractory to Standard Therapies
Sponsor:
Klus Pharma Inc
Organization:
Klus Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
| Epithelial Ovarian Cancer |
| Gastric Adenocarcinoma |
| Gastroesophageal Junction Adenocarcinoma |
| Urothelial Carcinoma |
| Non-Small Cell Lung Cancer |
| Small-Cell Lung Cancer |
| Endometrial Carcinoma |
| Head and Neck Squamous Cell Carcinoma |
Keywords:
| Name | View |
|---|---|
| TROP2 ADC | View |